Key Points - Multiple law firms remind investors of upcoming September 28, 2026 deadline to file lead plaintiff motion in class action against Capricor Therapeutics, Inc. (CAPR) - Investors who purchased CAPR securities between December 17, 2025 and July 26, 2026 may be entitled to compensation - Shareholders have specific rights under federal securities law...
uCloudlink Group Inc. (UCL) - This analysis reviews how the stock price reacted after the last...
Eltek Ltd. (ELTK) - This analysis reviews how the stock price reacted after the last 12...
TH International Limited (THCH) - This analysis reviews how the stock price reacted after the last...
Kandi Technologies Group, Inc. (KNDI) - This analysis reviews how the stock price reacted after the...
from William Blair issued a price target of $24.00 for OOMA on 2026-08-17 13:42:00.The adjusted price target was set to $24.00.At the time of the announcement, OOMA was trading at...
Bobby Brooks from Northland Securities issued a price target of $37.00 for ISSC on 2026-08-17 13:14:56.The adjusted price target was set to $37.00.At the time of the announcement, ISSC was...
Martin Fan from Wedbush issued a price target of $45.00 for IMUX on 2026-08-17 11:18:16.The adjusted price target was set to $45.00.At the time of the announcement, IMUX was trading...
from Piper Sandler issued a price target of $49.00 for RIGL on 2026-08-17 11:05:05.The adjusted price target was set to $49.00.At the time of the announcement, RIGL was trading at...
from Guggenheim issued a price target of $104.00 for SPRB on 2026-08-17 11:04:00.The adjusted price target was set to $104.00.At the time of the announcement, SPRB was trading at $52.64.The...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
